| scholarly article | Q13442814 |
| P2093 | author name string | Bo Shen | |
| Yi-Te Hsu | |||
| Robert S Smith | |||
| Julie Chao | |||
| Lee Chao | |||
| P2860 | cites work | Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest | Q24311735 |
| Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains | Q24318678 | ||
| Kallistatin is a potent new vasodilator | Q24561603 | ||
| Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel | Q28189283 | ||
| Expression of kallikrein-binding protein and alpha 1-antitrypsin genes in response to sex hormones, growth, inflammation and hypertension | Q28570653 | ||
| Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release | Q28609861 | ||
| Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation | Q33262479 | ||
| The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. | Q33906184 | ||
| DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells | Q33929217 | ||
| Kallistatin is a new inhibitor of angiogenesis and tumor growth | Q34154808 | ||
| Structural elements of kallistatin required for inhibition of angiogenesis | Q34195175 | ||
| Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli | Q34343869 | ||
| Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease | Q34382306 | ||
| Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy | Q34409943 | ||
| Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells | Q34984247 | ||
| Cardiovascular and renal control in NOS-deficient mouse models | Q35061516 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| TAK1 is a central mediator of NOD2 signaling in epidermal cells | Q36528456 | ||
| The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes | Q36855661 | ||
| Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells | Q37139048 | ||
| Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells | Q37415807 | ||
| The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells | Q38292167 | ||
| Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. | Q39821682 | ||
| Leukocyte-endothelial adhesion molecules | Q40392834 | ||
| Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase | Q40512506 | ||
| Identification of a new tissue-kallikrein-binding protein | Q42165219 | ||
| Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase | Q44333254 | ||
| A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 | ||
| Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation | Q45882701 | ||
| Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction | Q46397663 | ||
| Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress | Q46662638 | ||
| TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury | Q46872639 | ||
| Kruppel-like factor 4 regulates endothelial inflammation. | Q55043476 | ||
| Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery | Q64380933 | ||
| Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation | Q71650202 | ||
| Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver | Q72517519 | ||
| Alkaline phosphatase fusion proteins for molecular characterization and cloning of receptors and their ligands | Q73110172 | ||
| Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats | Q73157193 | ||
| Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock | Q73287311 | ||
| Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation | Q73707587 | ||
| Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
| Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA | Q80146633 | ||
| P433 | issue | 51 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| inflammation | Q101991 | ||
| P304 | page(s) | 35471-35478 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression | |
| P478 | volume | 284 |
| Q24307913 | A regulatory role of Kruppel-like factor 4 in endothelial argininosuccinate synthetase 1 expression in response to laminar shear stress |
| Q36389929 | Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report |
| Q49179977 | Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin. |
| Q38980848 | Circulating Endothelial Cells Expressing the Angiogenic Transcription Factor Krüppel-Like Factor 4 are Decreased in Patients with Coronary Artery Disease |
| Q50238802 | Codon optimization increases human kallistatin expression in Escherichia coli. |
| Q92409363 | Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature |
| Q33787467 | Hemodynamic disturbed flow induces differential DNA methylation of endothelial Kruppel-Like Factor 4 promoter in vitro and in vivo |
| Q87170742 | Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis |
| Q45069805 | Induction of Krüppel-like factor 4 expression in reactive astrocytes following ischemic injury in vitro and in vivo. |
| Q38631767 | KLF4 Regulation of Ch25h and LXR Mitigates Atherosclerosis Susceptibility |
| Q64103582 | KLF4 activates NFκB signaling and esophageal epithelial inflammation via the Rho-related GTP-binding protein RHOF |
| Q33939375 | Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6 |
| Q34357797 | Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling |
| Q89544590 | Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway |
| Q95260601 | Kallistatin correlates with inflammation in abdominal aortic aneurysm and suppresses its formation in mice |
| Q42101794 | Kallistatin levels in HIV-infected patients and effects of statin therapy |
| Q37732963 | Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation |
| Q39252905 | Kallistatin suppresses cancer development by multi-factorial actions |
| Q35654838 | Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis |
| Q38031130 | Kruppel-like factors and vascular inflammation: implications for atherosclerosis |
| Q37054152 | Krüppel-Like Factor 4 Is a Regulator of Proinflammatory Signaling in Fibroblast-Like Synoviocytes through Increased IL-6 Expression. |
| Q39151066 | Krüppel-like factor 4 (KLF4): What we currently know |
| Q38696354 | Krüppel-like factor 4 regulates the expression of inducible nitric oxide synthase induced by TNF-α in human fibroblast-like synoviocyte MH7A cells |
| Q34246141 | Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation |
| Q47676828 | Krüppel-like factors and vascular wall homeostasis. |
| Q92378153 | Mechanosensing and Mechanoregulation of Endothelial Cell Functions |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q35070827 | Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells |
| Q33916127 | Physiological stress-induced corticosterone increases heme uptake via KLF4-HCP1 signaling pathway in hippocampus neurons |
| Q37133031 | Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents |
| Q60921787 | Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation |
| Q42360588 | Protective Role of Kallistatin in Vascular and Organ Injury |
| Q26852339 | Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis |
| Q39458426 | Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression |
| Q37071386 | Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension |
| Q89466802 | Shear Stress Regulation of Endothelium: A Double-edged Sword |
| Q28116272 | Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium |
| Q37602866 | Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. |
| Q26741231 | The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm |
| Q35887767 | Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation |
| Q38873644 | c-Kit+ progenitors generate vascular cells for tissue-engineered grafts through modulation of the Wnt/Klf4 pathway. |
| Q38383813 | miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. |
Search more.